Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Circassia Pharmaceuticals PLC (CSSPF)
OTHER OTC:CSSPF
RESEARCH TOOLSreports
Holding CSSPF?
Track your performance easily
CSSPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.00 - $83.36
Previous Close$2.74
Volume5.00
Average Volume (3M)1.20K
Market Cap
$386.24M
Enterprise Value$361.14M
Total Cash (Recent Filing)£19.90M
Total Debt (Recent Filing)£1.10M
Price to Earnings (P/E)78.5
Beta-1.51
Next Earnings
Mar 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2024Dividend Yield1.45%
Share Statistics
EPS (TTM)0.03
Shares Outstanding422,120,630
10 Day Avg. Volume0
30 Day Avg. Volume1,200
Standard Deviation0.20
R-Squared0.14
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)3.75
Price to Sales (P/S)7.89
Price to Cash Flow (P/CF)22.00
P/FCF Ratio22.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1.04Price Target Upside39.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Circassia Pharmaceuticals News
PremiumCompany Announcements
Circassia Pharmaceuticals Announces Strong H1 2024 Results
PremiumCompany Announcements
Circassia Pharmaceuticals Announces Share BuybackPremiumCompany Announcements
Circassia Pharmaceuticals Reports Shareholding Shift
PremiumCompany Announcements
NIOX Group PLC Achieves Strong H1 Growth
PremiumCompany Announcements
Circassia Pharmaceuticals Strengthens Board with New Appointment
PremiumCompany Announcements
NIOX CFO’s Spouse Trades Company SharesPremiumCompany Announcements
Niox Group PLC Announces Major Shareholding Changes
PremiumCompany Announcements
Harwood Capital Adjusts Stake in Circassia PharmaceuticalsOptions Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
CSSPF FAQ
What was Circassia Pharmaceuticals PLC’s price range in the past 12 months?
Circassia Pharmaceuticals PLC lowest stock price was $0.00 and its highest was $83.36 in the past 12 months.
What is Circassia Pharmaceuticals PLC’s market cap?
Currently, no data Available
When is Circassia Pharmaceuticals PLC’s upcoming earnings report date?
Circassia Pharmaceuticals PLC’s upcoming earnings report date is Mar 25, 2025 which is in 180 days.
How were Circassia Pharmaceuticals PLC’s earnings last quarter?
Circassia Pharmaceuticals PLC released its earnings results on Sep 24, 2024. The company reported $0.013 earnings per share for the quarter, beating the consensus estimate of N/A by $0.013.
Is Circassia Pharmaceuticals PLC overvalued?
According to Wall Street analysts Circassia Pharmaceuticals PLC’s price is currently Undervalued.
Does Circassia Pharmaceuticals PLC pay dividends?
Circassia Pharmaceuticals PLC pays a Notavailable dividend of $0.01 which represents an annual dividend yield of 1.45%. See more information on Circassia Pharmaceuticals PLC dividends here
What is Circassia Pharmaceuticals PLC’s EPS estimate?
Circassia Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Circassia Pharmaceuticals PLC have?
Currently, no data Available
What happened to Circassia Pharmaceuticals PLC’s price movement after its last earnings report?
Circassia Pharmaceuticals PLC reported an EPS of $0.013 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -51.005%.
Which hedge fund is a major shareholder of Circassia Pharmaceuticals PLC?
Currently, no hedge funds are holding shares in CSSPF
---
Circassia Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.04 (39.22% Upside)
$1.04 (39.22% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.48%
12-Months-Change
Fundamentals
Return on Equity
13.52%
Trailing 12-Months
Asset Growth
-8.66%
Trailing 12-Months
Company Description
Circassia Pharmaceuticals PLC
Circassia Group PLC is a biotechnology company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of revenue from the US and also has a presence in EU, Asia Pacific and Rest of world.
---
CSSPF Stock 12 Month Forecast
Average Price Target
$1.04
▲(39.22% Upside)
Technical Analysis
Creo Medical
―
EKF Diagnostics Holdings
―
Futura Medical
―
Circassia Pharmaceuticals
―
Synairgen
―
Best Analysts Covering CSSPF
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-3.80%
reiterated a buy rating 3 days ago
Copying James Orsborne's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -3.80% per trade.
---